Evidence map›Paper›PMID 11507220›Full record

ArticleJournal of virology2001

Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.

J R Taylor, K C Kimbrell, R Scoggins, M Delaney, L Wu, D Camerini

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Glucose transporter 1 expression identifies a population of cycling CD4+ CD8+ human thymocytes with high CXCR4-induced chemotaxis.Proceedings of the National Academy of Sciences of the United States of America · 2005
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

J R TaylorDepartment of Microbiology and Myles H. Thaler Center for AIDS and Human Retrovirus Research, University of Virginia, Charlottesville, Virginia 22908, USA.
K C Kimbrell
R Scoggins
M Delaney
L Wu
D Camerini
University of Virginia · USAstraZeneca (United States) · US

Funding

INFECTIOUS DISEASES TRAINING PROGRAMT32AI007046 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI Alison K Criss, William A Petri · 1985 to 2026
$15.3M
PATHOGENESIS OF R5 HIV-1 ISOLATESR01AI047729 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI CAMERINI, DAVID · 2000 to 2004
$1.5M
TESTING ANTIHIV-1 GENE THERAPY IN SCID-HU MICER29AI039943 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI CAMERINI, DAVID · 1996 to 2000
$76k
NIAID NIH HHS R01 AI047729NIAID NIH HHS R01AI47729NIAID NIH HHS R29AI39943NIAID NIH HHS T32 AI007046NIAID NIH HHS T32AI07046
6 · The paper itself

Abstract

The presence or absence of the receptor CD4 and the coreceptors CCR5 and CXCR4 restrict the cell tropism of human immunodeficiency virus type 1 (HIV-1). Despite the importance of thymic infection by HIV-1, conflicting reports regarding the expression of HIV-1 coreceptors on human thymocytes have not been resolved. We assayed the expression and function of the major HIV-1 coreceptors, CCR5 and CXCR4, as well as CCR4 and CCR7 as controls, on human thymocytes. We detected CCR5 on 2.5% of thymocytes, CXCR4 on 53% of the cells, and CCR4 on 16% and CCR7 on 11% of human thymocytes. Moreover, infection by R5 HIV-1 did not significantly induce expression of CCR5. We found that two widely used anti-CCR5 monoclonal antibodies cross-reacted with CCR8, which may account for discrepancies among published reports of CCR5 expression on primary cells. This cross-reactivity could be eliminated by deletion of amino acids 2 through 4 of CCR8. Chemotaxis assays showed that SDF-1, which binds CXCR4; MDC, which binds CCR4; and ELC, which binds CCR7, mediated significant chemotaxis of thymocytes. In contrast, MIP-1beta, whose receptor is CCR5, did not induce significant chemotaxis. Our results indicate that CXCR4, CCR4, CCR7, and their chemokine ligands may be involved in thymocyte migration during development in the thymus. CCR5 and its ligands, however, are likely not involved in these processes. Furthermore, the pattern of CCR5 and CXCR4 expression that we found may explain the greater susceptibility of human thymocytes to infection by HIV-1 isolates capable of using CXCR4 in cell entry compared to those that use only CCR5.

Indexed as

Amino Acid SequenceAnimalsAntibodies, MonoclonalChemokine CCL19Chemokine CCL22Chemokine CCL4Chemokine CXCL12Chemokines, CCChemokines, CXCChemotaxisCross ReactionsDisease Models, AnimalHIV-1HIV InfectionsHumansMacrophage Inflammatory ProteinsAntibodies, MonoclonalCCL19 protein, humanCcl19 protein, mouseCCL22 protein, humanCcl22 protein, mouseCCR4 protein, humanCcr4 protein, mouseCCR7 protein, humanCcr7 protein, mouseCCR8 protein, humanChemokine CCL19Chemokine CCL22Chemokine CCL4Chemokine CXCL12Chemokines, CCChemokines, CXCCXCL12 protein, humanCxcl12 protein, mouseMacrophage Inflammatory ProteinsReceptors, CCR4Receptors, CCR5Receptors, CCR7Receptors, CCR8Receptors, ChemokineReceptors, CXCR4

Identifiers

PMID11507220
PMCPMC115120
OpenAlexW2076760824

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.